2-3

Cipla known for its innovative pharmaceutical products backed by latest in technology and creative marketing practices, is enjoying a commanding position among the top pharma companies in the country.
Several specialised therapeutic divisions and promising new products have been launched and many more are in the pipeline.

Wanbury Limited (Formerly Pearl Organics Limited) is the largest producer and exporter of Metformin Hydrochloride and Salsalate in the world, with production capacity in excess of 3000 Tons per year and supply to over 50 countries, with 65% share in the regulated markets. It is also the leading supplier of bulk drugs to the top 5 generic players in the US. The company has plants at Patalganga, Tarapur and Tanuku (Andhra Pradesh) of which 2 are US – FDA approved and also of EDQM standards.

SRINI PHARMACEUTICALS LIMITED is a 12-year old Company having its US FDA and TGA inspected and approved manufacturing facility 60 kilometers away from the Pharma Capital of India, Hyderabad. The facility has four full-fledged production blocks with the efficient utilities including steam, chilled water, nitrogen generation, cooling water, vacuum and compressed air. It has state-of-the-art centralized quality control lab and R&D Lab.

Advinus Therapeutics (A TATA Enterprise) is an R&D driven company that is focused on the new drug discovery and development of pharmaceutical and agrochemical products.
Advinus operations are organized into two separate businesses centered around Discovery and Development respectively.

National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an 'Institute of National Importance'.

Cipla known for its innovative pharmaceutical products backed by latest in technology and creative marketing practices, is enjoying a commanding position among the top pharma companies in the country.
Several specialised therapeutic divisions and promising new products have been launched and many more are in the pipeline.